Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
727,900
-361,580
-33% -$5.6M 0.14% 226
2026
Q1
$14.7M Buy
1,089,480
+97,420
+10% +$1.36M 0.22% 122
2025
Q4
$12.4M Buy
992,060
+354,360
+56% +$3.82M 0.19% 139
2025
Q3
$6.31M Buy
+637,700
New +$6.21M 0.11% 340
2020
Q1
Sell
-81,074
Closed -$1.63M 526
2019
Q4
$1.63M Buy
81,074
+53,209
+191% +$990K 0.49% 72
2019
Q3
$551K Buy
+27,865
New +$546K 0.21% 143
2016
Q3
Sell
-5,957
Closed -$258K 444
2016
Q2
$258K Buy
+5,957
New +$264K 0.1% 291

Other funds holding VTRS

Algert Global's VTRS Position: Q2 2026 in Review

Algert Global reduced its Viatris (VTRS) stake by 33% in Q2 2026, selling an estimated $5.6M and leaving 727,900 shares worth $11.6M. The position accounts for 0.14% of the portfolio, ranked #226.

Algert Global first reported a position in VTRS in Q2 2016 and has held it in 7 quarters since. The position peaked at $14.7M in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Algert Global held 727,900 shares of Viatris worth $11.6M as of Q2 2026.
  • Algert Global sold 361,580 Viatris shares in Q2 2026, an estimated $5.6M.
  • Viatris made up 0.14% of Algert Global's portfolio in Q2 2026, its #226 holding.
  • Algert Global first reported a position in Viatris in Q2 2016 and has held it in 7 quarters since.
  • Algert Global's Viatris position peaked at $14.7M in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.